Systematic review and meta-analysis of indirect protection afforded by vaccinating children against seasonal influenza: Implications for policy

Clinical Infectious Diseases

Volumn 65, Issue 5, 2017, Pages 719-728

  Yin, J Kevin ^a,b,c   Heywood, Anita E ^d   Georgousakis, Melina ^a,b,c   King, Catherine ^a,b,e   Chiu, Clayton ^a,b,e   Isaacs, David ^b,e   Macartney, Kristine K ^a,b,e  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b Childrens Hospital at Westmead   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e University of Sydney   (Australia)

Author keywords

Children; Immunization policy; Indirect protection; Influenza vaccine; Seasonal influenza

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CHILDHOOD DISEASE; HEALTH CARE POLICY; HUMAN; INFLUENZA VACCINATION; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEASONAL INFLUENZA; SYSTEMATIC REVIEW; ADOLESCENT; CHILD; HERD IMMUNITY; IMMUNOLOGY; INFANT; INFLUENZA; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNITY, HERD; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 85032192204     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix420     Document Type: Article

References (62)

1. World Health Organization. Vaccines against influenza WHO position paper-November 2012. Wkly Epidemiol Rec 2012; 87:461-76.
2. National Advisory Committee on Immunization, Canada. Canadian immunization guide chapter on influenza and statement on seasonal influenza vaccine for 2016-2017. Available at: http://www.phac-aspc.gc.ca/naci-ccni/assets/pdf/flu-2016-2017-grippe-eng.pdf. Accessed 14 February 2017.
3. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 2016; 65:1-54.
4. McGuire A, Drummond M, Keeping S. Childhood and adolescent influenza vaccination in Europe: a review of current policies and recommendations for the future. Expert Rev Vaccines 2016; 15:659-70.
5. Australian Technical Advisory Group on Immunisation. ATAGI advice for immunisation providers regarding the administration of seasonal influenza vaccines in 2017. Available at: http://www.immunise.health.gov.au/internet/immunise/ publishing.nsf/Content/ATAGI-advice-influenza-vaccines-providers. Accessed 6 March 2017.
6. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362:1733-45.
7. Fine PEM, Mulholland K. Chapter 71: community immunity. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 6th ed. Philadelphia, PA: Saunders Elsevier, 2012.
8. World Health Organization. Principles and considerations for adding a vaccine to a national immunization programme: from decision to implementation and monitoring. Available at: http://apps.who.int/iris/bitstr eam/10665/111548/1/9789241506892-eng.pdf?ua=1. Accessed 7 October 2016.
9. Erickson LJ, De Wals P, Farand L. An analytical framework for immunization programs in Canada. Vaccine 2005; 23:2470-6.
10. Yin JK, Heywood A, Georgousakis M, et al. Systematic review and meta-analysis of herd protection derived from vaccinating children against seasonal influenza: implications for policy. 2016. Available at: http://www.crd.york.ac.uk/ PROSPERO/display-record.asp?ID=CRD42012003449.
11. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339:b2700.
12. Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64:401-6.
13. Higgins JPT, Green S. Chapter 8: assessing risk of bias in included studies. In: Cochrane handbook for systematic reviews of interventions. 5.1.0 ed. London, UK: The Cochrane Collaboration, 2011.
14. Clemens J, Shin S, Ali M. New approaches to the assessment of vaccine herd protection in clinical trials. Lancet Infect Dis 2011; 11:482-7.
15. Longini IM Jr, Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD. Controlling endemic cholera with oral vaccines. PLoS Med 2007; 4:e336.
16. Poole C, Greenland S. Random-effects meta-analyses are not always conservative. Am J Epidemiol 1999; 150:469-75.
17. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-101.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539-58.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60.
20. Charu V, Viboud C, Simonsen L, et al. Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren. PLoS One 2011; 6:e26282.
21. Davis MM, King JC Jr, Moag L, Cummings G, Magder LS. Countywide schoolbased influenza immunization: direct and indirect impact on student absenteeism. Pediatrics 2008; 122:e260-5.
22. Esposito S, Marchisio P, Cavagna R, et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine 2003; 21:3162-8.
23. Ghendon YZ, Kaira AN, Elshina GA. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2006; 134:71-8.
24. Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis 2010; 202:1626-33.
25. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000; 284:1677-82.
26. King JC Jr, Cummings GE, Stoddard J, et al; SchoolMist Study Group. A pilot study of the effectiveness of a school-based influenza vaccination program. Pediatrics 2005; 116:e868-73.
27. King JC Jr, Lichenstein R, Cummings GE, Magder LS. Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland. Vaccine 2010; 28:7737-42.
28. King JC Jr, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006; 355:2523-32.
29. Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010; 303:943-50.
30. Monto AS, Davenport FM, Napier JA, Francis T Jr. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 1970; 122:16-25.
31. Pannaraj PS, Wang HL, Rivas H, et al. School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance. Clin Infect Dis 2014; 59:325-32.
32. Pebody R, Green HK, Andrews N, et al. Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15. Euro Surveill 2015; 20. pii:30029.
33. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005; 23:1540-8.
34. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007; 120:e553.
35. Plaspohl SS, Dixon BT, Streater JA, Hausauer ET, Newman CP, Vogel RL. Impact of school flu vaccine program on student absences. J Sch Nurs 2014; 30:75-80.
36. Principi N, Esposito S, Marchisio P, Gasparini R, Crovari P. Socioeconomic impact of influenza on healthy children and their families. Pediatr Infect Dis J 2003; 22:S207-10.
37. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344:889-96.
38. Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 1993; 168:881-7.
39. Tran CH, Sugimoto JD, Pulliam JR, et al. School-located influenza vaccination reduces community risk for influenza and influenza-like illness emergency care visits. PLoS One 2014; 9:e114479.
40. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, coldadapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998; 338:1405-12.
41. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis 1991; 163:300-4.
42. Colombo C, Argiolas L, La Vecchia C, Negri E, Meloni G, Meloni T. Influenza vaccine in healthy preschool children. Rev Epidemiol Sante Publique 2001; 49:157-62.
43. Cowling BJ, Ng S, Ma ES, et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010; 51:1370-9.
44. Gruber WC, Taber LH, Glezen WP, et al. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child 1990; 144:595-600.
45. Hull HF, McBean A, Caldwell D, O'Connor H. Assessing herd immunity in the elderly following the vaccination of school children with live attenuated trivalent influenza vaccine (LAIV): a county level analysis. Procedia Vaccinol 2010; 2:92-100.
46. Kjos SA, Irving SA, Meece JK, Belongia EA. Elementary school-based influenza vaccination: evaluating impact on respiratory illness absenteeism and laboratory-confirmed influenza. PLoS One 2013; 8:e72243.
47. McBean M, Hull HF, O'Connor H. Possible herd immunity in the elderly following the vaccination of school children with live, attenuated trivalent influenza vaccine: a person level analysis. Procedia Vaccinol 2011; 4:59-70.
48. Pebody RG, Green HK, Andrews N, et al. Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season. Euro Surveill 2014; 20. pii:30029.
49. Talbot HK, Poehling KA, Williams JV, et al. Influenza in older adults: impact of vaccination of school children. Vaccine 2009; 27:1923-7.
50. Loeb M, Russell ML, Manning V, et al. Live attenuated versus inactivated influenza vaccine in Hutterite children: a cluster randomized blinded trial. Ann Intern Med 2016; 165:617-24.
51. Jordan R, Connock M, Albon E, et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 2006; 24:1047-62.
52. Baguelin M, Jit M, Miller E, Edmunds WJ. Health and economic impact of the seasonal influenza vaccination programme in England. Vaccine 2012; 30:3459-62.
53. Cohen S, Chui K, Naumova E. Influenza vaccination in young children reduces influenza associated hopsitalisations in older adults, 2002-2006. J Am Geriatric Soc 2011; 59:327-32.
54. Pitman RJ, White LJ, Sculpher M. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine 2012; 30:1208-24.
55. Weycker D, Edelsberg J, Halloran ME, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005; 23:1284-93.
56. Van Vlaenderen I, Van Bellinghen LA, Meier G, Nautrup BP. An approximation of herd effect due to vaccinating children against seasonal influenza - A potential solution to the incorporation of indirect effects into static models. BMC Infect Dis 2013; 13:25.
57. Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5:e74.
58. Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, Edmunds WJ. Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med 2013; 10:e1001527.
59. Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2014-15 influenza season. Available at: http://www.cdc.gov/flu/fluvaxview/ coverage-1415estimates.htm. Accessed 7 October 2016.
60. Kassianos G, White S, Reynolds AJ, Rajaram S. Review of the experiences from the first childhood influenza vaccination programme with a live attenuated influenza vaccine in England and Scotland. Drugs Context 2015; 4:212280.
61. Kwong JC, Pereira JA, Quach S, et al; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group. Randomized Evaluation of Live Attenuated vs. Inactivated Influenza Vaccines in Schools (RELATIVES) cluster randomized trial: pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination. Vaccine 2015; 33:4910-5.
62. Thorrington D, Jit M, Eames K. Targeted vaccination in healthy school children- can primary school vaccination alone control influenza? Vaccine 2015; 33:5415-24.